Triterpenoids-templated self-assembly nanosystem for biomimetic delivery of CRISPR/Cas9 based on the synergy of TLR-2 and ICB to enhance HCC immunotherapy
Authors:
Open Access
- 8 May 2024
- journal article
- research article
- Published by Elsevier in Acta Pharmaceutica Sinica B
- Vol. 14 (7) , 3205-3217
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (82172767)
This publication has 37 references indexed in Scilit:
- Ferroptosis-induced anticancer effect of resveratrol with a biomimetic nano-delivery system in colorectal cancer treatmentAsian Journal of Pharmaceutical Sciences, 2022
- Biomembrane-based nanostructures for cancer targeting and therapy: From synthetic liposomes to natural biomembranes and membrane-vesiclesAdvanced Drug Delivery Reviews, 2021
- Self‐Assembly of NanographenesAngewandte Chemie International Edition, 2021
- A smart dual-drug nanosystem based on co-assembly of plant and food-derived natural products for synergistic HCC immunotherapyActa Pharmaceutica Sinica B, 2021
- MiR-520a-3p inhibits malignant progression of epithelial ovarian cancer by targeting SUV39H1 expressionHuman Cell, 2020
- Evolution from small molecule to nano-drug delivery systems: An emerging approach for cancer therapy of ursolic acidAsian Journal of Pharmaceutical Sciences, 2020
- Inhibition of glycosidase by ursolic acid: in vitro, in vivo and in silico studyJournal of the Science of Food and Agriculture, 2019
- Red blood cell membrane-camouflaged nanoparticles: a novel drug delivery system for antitumor applicationActa Pharmaceutica Sinica B, 2019
- Immune checkpoint blockade and its combination therapy with small-molecule inhibitors for cancer treatmentBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2019
- Simultaneous inhibition of growth and metastasis of hepatocellular carcinoma by co-delivery of ursolic acid and sorafenib using lactobionic acid modified and pH-sensitive chitosan-conjugated mesoporous silica nanocomplexBiomaterials, 2017